Dados B3Stocks › BIOM3 PT

Saúde

BIOM3 — BIOMM SA

CNPJ 04.752.991/0001-10 · listed classes: BIOM3 · CVM code 19305

-146.5P/E
3.1P/B
310.5EV/EBITDA
-14.1%FCF yield
-2.3%ROE 2025
-1.1%ROIC 2025
P/E, P/B and EV/EBITDA priced at the session of 2026-03-25 (R$ 7.16), the first one after the 2025 filing became public on 2026-03-25 — point-in-time, not the 31 December price. pl_negativo

The full history, year by year

The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.

indicator2010201120122013201420152016201720182019202020212022202320242025
ROE -23.1%-11.8%7.5%-50.4%-60.9%-51.5%-43.0%-41.0%-53.0%-68.4%-59.1%-40.0%-2.3%
ROIC -12.3%!-13.6%!-2.1%!-18.9%!-14.7%!-14.1%!-18.5%!-16.6%!-18.1%!-24.4%!-21.3%!-23.1%!-1.1%!
ROA -87.1%!-53.6%-135.5%-13.7%-8.0%4.0%-19.5%-15.3%-15.0%-16.1%-17.2%-19.9%-23.9%-21.6%-19.1%-1.4%
Gross margin 50.3%35.0%15.6%5.8%23.8%25.2%15.2%19.7%12.5%31.6%
EBIT margin -483.7%!-34,389.3%!-2,341.9%!-588.2%!-94.7%-61.3%-82.2%-61.4%-56.8%-1.9%
Net margin -487.2%-37,017.5%-2,717.9%-624.0%-120.6%-74.9%-88.2%-68.7%-54.0%-2.5%
Revenue growth (1y) -100.0%!1,420.4%471.1%555.9%82.5%-2.0%12.6%20.9%88.4%
Revenue growth (5y CAGR) 299.6%137.4%74.1%35.6%
Net debt/EBITDA 16.05x
Current ratio 0.43x0.38x0.08x9.26x16.42x9.41x2.61x1.49x2.66x2.44x3.03x1.80x1.98x1.52x2.72x2.23x

The current year, quarter by quarter

As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.

quarterrevenueprofitnet marginP/E TTMP/Bfiled on
2024T1!38.6-17.1-44.3%-32.16.202024-05-15
2024T2!32.1-18.3-57.0%-18.73.712024-08-13
2024T3!32.3-16.3-50.5%-20.14.212024-11-13
2025T1!39.6-11.7-29.6%-16.65.102025-05-15
2025T2!27.2-13.7-50.6%-12.53.812025-08-14
2025T3!35.8-10.6-29.6%-14.13.612025-11-14
2026T1!92.519.020.6%-152.53.152026-05-15
2026T289.41.82.1%87.72.402026-08-14

Full series, every quarter: GET /empresas/BIOM3/trimestres

Dividends per year

No dividends recorded. Note this can mean two different things — the company pays none, or we could not confirm. sem_proventos

Piotroski F-Score 4/9 (2025) — what each criterion means.

Restated filings for this company

The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.

fiscal yearaccountfirst filingrestated
2018BPA 1.01.018.113.3
2014DFC_MI 6.01-20.0-16.7
2019DFC_MI 6.01-80.5-77.2
2018DFC_MI 6.01-45.0-46.8
2020DFC_MI 6.01-96.6-95.0
2012BPA 18.37.0
2012BPP 28.37.0
2010DMPL 5.05.01-4.0-4.3

This company appears in

Other companies in Healthcare

15 more with a page, same CVM sector — a classification of the regulator's, not ours.

Take this into your code

Everything on this page is also JSON: GET /empresas/BIOM3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).

Price coverage: 2,843 sessions, 2010-04-23 → 2026-09-04 · methodology · how we verify

Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 11:12 UTC. If this does not match /saude, you are reading a cached copy.